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Abstract
Background: Sufficient iodine intake is needed during pregnancy to ensure proper fetal development. The iodine
levels of women in their first trimester of pregnancy in Catalonia are currently unknown. This data would help to
determine whether our public health services should establish recommendations or interventions in this line. The
aim of this study was to investigate the iodine nutritional status, prevalence of urinary iodine <150 μg/L, and
tobacco use in the first trimester of pregnancy in our setting.
Methods: Cross-sectional study. Data were collected during 2008–2009 from women in their first trimester at the
primary care centers of the province of Barcelona (Spain). Pregnant women included in the study completed a
questionnaire on eating habits and underwent urinary iodine concentration (UIC) assessment.
Results: Nine hundred forty five women completed the dietary questionnaire and urinary iodine testing. Median
UIC was 172 μg/L, with 407 participants (43.1%) showing levels <150 μg/L. On multivariate logistic regression
analysis, intake of 1–2 glasses of milk per day, OR = 0.636 95% CI (0.45–0.90) or >2 glasses, OR = 0.593 95% CI
(0.37–0.95); iodized salt consumption, OR = 0.678 95% CI (0.51–0. 90); and use of iodine supplementation,
OR = 0.410 95% CI (0.31–0.54), protected against the risk of UIC <150 μg/L. Simultaneous consumption of
iodized salt and milk (≥1 glass/day) showed a larger protective effect: OR = 0.427, 95% CI (0.31–0.54).
Conclusion: The median UIC of the pregnant women surveyed indicated an acceptable iodine nutritional status
according to the criteria established by the WHO and ICCIDD. The risk of urinary iodine <150 μg/L decreased with
simultaneous consumption of milk and iodized salt, similar to the decrease seen with iodine supplementation.
Background
A recent nationwide study conducted in Spain has reported
that iodine nutrition is adequate in the general population,
which showed a median urinary iodine concentration
(UIC) of 117 μg/L [1]. Nonetheless, in the subgroup of
women of childbearing age, median UIC was 114 μg/L, a
value indicating a situation of risk in pregnancy [1].
Iodine is an essential micronutrient that must be supplied
by regular intake in the food consumed. It has a vital func-
tion in the synthesis of thyroid hormones, which act on
several organs and body systems, and is especially
important for central nervous system development starting
from the earliest stages of embryonic and fetal growth [2].
Iodine requirements vary with age and the individual’s
physiological condition. In pregnancy, thyroid metabolism
undergoes a series of changes as the demand for iodine in-
creases due to embryonic and fetal development. Since
the early stages of pregnancy, the thyroid gland undergoes
stimulation due to the effect of chorionic gonadotropin
hormone [3]. There is an increase in the available blood
volume and the iodine distribution space, iodine is
transferred from the mother’s circulatory system to the
fetal-placental unit, and an increase in glomerular filtra-
tion leads to increasingly larger amounts of iodine being
eliminated in urine (30%–50%). This combination of
factors results in a high demand for iodine during
pregnancy [4–6]. During the first trimester, thyroid
hormones for embryonic and fetal tissues rely exclu-
sively on the available maternal hormones; hence,
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iodine deficiency in the mother may have a negative
impact on prenatal development [7]. Clinical studies
have reported a relationship of iodine deficiency and
maternal hypothyroxinemia during pregnancy with im-
paired neurocognitive and psychological development
of the children [3, 8–13]. Therefore, it is important to
increase iodine intake starting in the early stages of
pregnancy and, if possible, even beforehand. The World
Health Organization (WHO), together with the United
Nations International Children’s Emergency Fund
(UNICEF) and the International Council for Control of
Iodine Deficiency Disorders (ICCIDD), recommend a
daily iodine intake of between 200 and 250 μg/day during
pregnancy [14].
Under normal conditions, there is a balance between
iodine intake and urinary output, making the UIC a good
indicator of recently consumed iodine [15]. The median
UIC indicating optimum iodine intake in pregnant women
is 150 to 250 μg/L [14, 15]. Studies carried out in various
European countries, including Spain, have reported highly
variable values, ranging from 60 to 250 μg/L [16].
Several strategies can be applied to ensure an adequate
iodine supply and to correct deficiencies in this regard.
The WHO and other international agencies have advo-
cated universal salt iodization for worldwide consump-
tion. In cases where iodine requirements cannot be
guaranteed through diet during pregnancy, the WHO
recommends potassium iodide supplementation [14].
Another aspect to include when considering the
dietary and health habits of pregnant women is to-
bacco use and its impact on maternal thyroid func-
tion. Tobacco is considered a goitrogenic substance,
as it inhibits thyroid uptake of iodine [17]. Tobacco
use during pregnancy has been associated with
changes in thyroid function in both the mother and
fetus [18–20], and with changes in the UIC [21].
During lactation, tobacco use lowers the iodine content in
breast milk [22].
Currently, there is little available data on the iodine
nutritional status in pregnant woman in Catalonia (an
autonomous region in northeast Spain) or the dietary
habits that may be determinant in this regard. The avail-
able information comes from studies conducted in
limited areas of our region or in women in the third
term of pregnancy [23, 24]. To fill this gap, the aim of
this study was to determine the iodine status of a popu-
lation of pregnant women during the first trimester of
pregnancy—the time when thyroid deficiency can have
the greatest impact on embryonic development—and to
investigate the habits affecting the iodine status in this
population in a large geographical area of Catalonia. The
ultimate aim was to gain information that will be useful
to assess the need for interventions in this population by
a public health program.
Methods
Design
This is a cross-sectional descriptive study, based on in-
formation collected from women in their first trimester
of pregnancy in 2008–2009. The information was
obtained within the structure of a clinical trial whose
ultimate purpose is to evaluate the effect of an interven-
tion on eating habits and its benefits on iodine levels in
pregnant women [25]. The present report describes the
iodine status results in this population. The study was
approved by the Clinical Research Ethics Committee at
the Primary Care Research Institute (IDIAP) Jordi Gol.
Setting
The study was conducted within the framework of the
primary care center Program for Sexual and Reproduct-
ive Health Care (PASSIR) of the Catalonia Central and
Metropolitana Nord Regional Offices of the Institut
Català de la Salut (ICS, Catalonian Institute of Health)
in the province of Barcelona (Spain).
Participants
A consecutive recruitment was carried out within a clin-
ical trial framework. During 2008 and 2009, all women
older than 17 years who were seen in the participating
centers in their first trimester of pregnancy (<13 weeks)
and accepted to participate were included in the study.
Pregnant women with thyroid disease, no telephone
contact, or difficulty communicating with the health
personnel (cognitive, sensory, or language problems),
and those refusing to participate, were excluded. A
calculated sample size of 989 pregnant women was
needed to answer the hypothesis of the clinical trial [25].
Data collection
The socio-demographic data included patient age, place
of origin, place of residence (rural/urban), and educa-
tional level. Information on dietary and other habits was
collected at a personal interview by midwives in the par-
ticipating primary care centers, using a standardized
questionnaire [25] showing good reliability (Cronbach’s
alpha, 0.960 and intraclass correlation coefficient, 0.927).
The questionnaire contained items related to consump-
tion of cow milk (glasses/day; 1 glass = 200 mL), and fish
(servings/week), regular consumption of iodized salt
(Yes/No), daily use of iodine supplements (potassium
iodide or iodine vitamin supplements) (Yes/No), use of
iodinated antiseptics, and tobacco use.
Urinary iodine concentration (μg/L) was determined as
follows: A first morning urine sample was collected from
each woman, quickly frozen at −40 °C, and transported
within 24 to 48 h to a central laboratory (Barcelona
Hospital Clinic), where UIC determination was performed
using the Benotti & Benotti method [26]. Urine was first
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digested with chloric acid and then underwent the
Sandell-Kolthoff reaction, in which iodine was determined
by its action as a catalyst in the reduction of ceric ammo-
nium sulphate in the presence of arsenious acid. The
inter-assay and intra-assay coefficients of variation of the
technique were 15.5% and 12.6%, respectively. Three times
a year, the UIC assay undergoes evaluation by an external
quality assessment program from the Spanish Association
of Neonatal Screening (AECNE). UIC values were dichot-
omized as <150 μg/L (insufficient) and ≥150 μg/L
(adequate) [14] in the analyses.
Statistical analysis
Quantitative variables are described as the mean and
standard deviation or the median and first and third
quartiles (Q1-Q3) for those with a non-normal distribu-
tion. Categorical variables are expressed as the absolute
frequency and percentage.
The Student t test for independent data and the
Mann-Whitney U test, as appropriate, were used for
quantitative variables and the Pearson chi-square test for
categorical variables.
A multivariate logistic regression model was per-
formed, in which the dependent variable was UIC less
than or equal to 150 μg/L. The Initial model contained
all the covariates that individually had an association
with UIC according to a significance level of p ≤ 0.1.
The final model included statistically significant
(p < 0.05) covariates, while also considering Akaike’s in-
formation criterion and biological plausibility. Akaike’s
information criterion is a tool that balances the informa-
tion provided by a set of variables (goodness of fit) and
the principle of parsimony (use of the minimum possible
set of variables, less complexity), making it useful for
model selection.
All analyses were performed with SPSS for Windows,
version 22.0. Significance was set at a p-value of ≤0.05.
Results
In total, 985 pregnant women in their first trimester of
pregnancy were recruited. We were able to obtain the
urinary iodine concentration in 970 (98.5%) women, and
945 (95.6%) also answered the standardized questionnaire.
Characteristics of the sample
The mean age of the participants was 30.6 (4.6) years,
and 784 (83.0%) were Spanish. Most (696, 73.7%) were
from urban areas. The breakdown by educational level
was as follows: 5 (0.5%) had received no formal educa-
tion, 28 (3.0%) had not completed primary school, 232
(24.6%) had completed primary school, 393 (41.6%) had
completed secondary school, and 287 (30.4%) had a
university degree. As to tobacco use, 221 (23.4%) said that
they were smokers and 98 (10.4%) ex-smokers (had stopped
smoking less than 1 year previously, including those who
stopped in early pregnancy); 176 (20.4%) women continued
smoking during the first trimester of pregnancy.
Urinary iodine concentration
The median overall UIC [Q1-Q3] was 172 μg/L [103.8–
289.3]. UIC distribution is depicted in Fig. 1. Among the
total of participants, 43.1% had a UIC <150 μg/L and
8.8% a UIC >600 μg/L. Median UIC did not differ
according to the women’s place of residence (rural/urban),
place of origin, education level, use of iodinated antiseptics
(3.1% of the population), or tobacco use (Table 1). The
Spearman rho correlation coefficient between the number
of cigarettes smoked and UIC level was nil (r = −0.074,
p = 0.386). In total 337 (35.7%) women reported using
iodized salt. The median UIC was higher in this group
than in nonusers (189 vs 158 μg/L; p < 0.001) (Table 2).
The 442 (46.8%) women taking iodine supplementation
also showed a higher median UIC than those who did not
(209.5 vs 140 μg/L; p < 0.001 We found that an increase
in milk consumption was associated with a higher UIC
(139.5, 176, and 198 μg/L for 0, 1–2, and >2 glasses/day,
respectively; p = 0.003). The median UIC showed no
differences in relation to fish consumption.
Association with UIC <150 μg/L
Urinary iodine values were dichotomized into <150 μg/L
and ≥150 μg/L; 407 (43.1%) women had values below
150 μg/L (Tables 1 and 2). On bivariate analysis, UIC
<150 μg/L showed no relationship with the women’s
place of residence (urban or rural), place of origin, edu-
cation level, or smoking habit. However, higher milk
consumption (p = 0.016), iodized salt use (p < 0.001),
and iodine supplementation (p < 0.001) were associated
with UIC ≥150 μg/L (Table 2). No associations were
found between the UIC value and fish consumption or
exposure to iodinated antiseptics.
Multivariate analysis
To determine which of the variables studied were associ-
ated with an insufficient UIC, multivariate logistic re-
gression analysis was performed using UIC <150 μg/L as
the dependent variable and each of the sociodemo-
graphic variables and items on the dietary questionnaire
as independent variables.
In Model 1, milk consumption had a protective effect
on UIC <150 mg/L, which increased with increasing
milk consumption from 1 to 2 to >2 glasses/day (OR
0.636 [0.45–0.90] and 0.593 [0.37–0.95], respectively).
Iodine supplementation and iodized salt intake also pro-
vided a protective effect (OR 0.410 [0.31–0.54] and OR
0.678 [0.51–0.90], respectively) (Table 3).
In Model 2, daily consumption of 1 or more glasses of
milk was combined with iodized salt use (Table 3).
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Table 1 Characteristics of pregnant women and related urinary iodine level
Urinary Iodine
≥150 μg/L
Urinary Iodine
<150 μg/L
pa Urinary iodine (μg/L)
Median [Q3-Q3]
pb
TRIMESTER 1 n = 556 n = 414 n = 970
172.0 [103.8–289.3] —
Age 31.0 (4.5) 29.9 (4.6) <0.001 — —
Place of residence 0.526 0.976
Urban 413 (57.9%) 300 (42.1%) 157.5 [95.0–243.8]
Rural 143 (556%) 114 (44.4%) 154.0 [100.6–231.5]
Place of origin 0.127 0.335
Native of Spain 448 (57.1%) 336 (42.9%) 169.5 [102.2–287.5]
South America 47 (66.2) 24 (33.8%) 192.5 [94.1–309.3]
Africa 24 (46.2%) 28 (53.8%) 145.5 [95.3–211.3]
Other 19 (50.0%) 19 (50.0%) 135.0 [85.0–249.0]
Educational level 0.035 0.623
Illiterate 2 (40.0%) 3 (60.0%) 85.0 [47.6–204.0]
Incomplete primary school 13 (46.4%) 15 (53.6%) 148.0 [79.8–333.5]
Primary School 126 (54.3%) 106 (45.7%) 150.0 [103.5–238.5]
High School 221 (56.2%) 172 (43.8%) 154.0 [95.5–232.0]
University degree 176 (61.3%) 111 (38.7%) 163.0 [93.9–252.8]
Tobacco use 0.253 0.263
Non-smoker 374 (59.1%) 259 (40.9%) 181.0 [104.0–294.0]
Ex-smoker 54 (55.1%) 44 (44.9%) 168.0 [105.8–319.5]
Smoker 123 (53.0%) 109 (47.0%) 157.5 [98.1–242.5]
aPearson’s chi-square test
bMann-Whitney U test
Fig. 1 Histogram of the iodine concentration in the urine of pregnant women in their first trimester of pregnancy. The discontinuous line
indicates the value of urinary iodine recommended in pregnant women (≥150 mg/dL). The 43.1% of these women had UIC <150 mg/dL
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Consumption of iodized salt alone was a protective fac-
tor, but was non-significant, likely because of the rela-
tively small number of women who used this product
(OR 0.704 [0.38–1.32]; p = 0.276). However, intake of a
single glass of milk yielded a protective effect (OR 0.641
[0.42–0.98]; p = 0.039), which was even greater if com-
plemented with iodized salt consumption (OR 0.0.427
[0.27–0.66]; p < 0.001), in a manner similar to the effect
of iodine supplementation (OR 0.411 [0.31–0.54];
p < 0.001).
Discussion
The median UIC of pregnant women in their first tri-
mester (172 μg/L) indicated an adequate iodine nutri-
tional status (≥150 μg/L) [14], although 43.1% of the
sample showed values <150 μg/L. This overall finding is
consistent with the results obtained in studies conducted
in adults and children (4 and 6 years old) from Catalo-
nia, which reported UICs indicative of adequate iodine
nutrition [27–29]. In our study, iodine status of the
pregnant women included did not differ according to
the place of residence (rural or urban), place of origin
(native or immigrant), education level, or tobacco use.
The median UIC we found (172 μg/L) was notably
higher than that obtained in a study performed in 2010
by Alvarez-Pedrerol et al. in Sabadell, an area within the
setting of our study. In total, 600 women in the third
trimester were included and the median UIC was
104 μg/L [23]. These differences may be explained by
the lower consumption of iodized salt in that population
compared to our cohort (11.5% vs 35.7%). In another
study, including 267 pregnant women in the first trimes-
ter in two areas of Catalonia, 139 in a mountain area
and 128 in coastal area, the median UIC was found to
be higher (coastal area, 142 μg/L and mountain area
209 μg/L); iodized salt was used by 36.4% and 58% of
the women, respectively [24].
In a study including a sample of 1844 women in the
first trimester of pregnancy from 3 areas of Spain
(Valencia, Guipúzcoa, Sabadell), the median UIC was
lower than 150 μg/L in Valencia and Sabadell, but not in
Guipúzcoa [30]. In a study conducted in Toledo (Spain)
including 525 pregnant women, the median UIC was
164 μg/L [31]. The women were divided into 3 groups:
69 pregnant women who did not use iodized salt or iod-
ine supplementation, 75 pregnant women who used
iodized salt but not supplementation, and 381 pregnant
women who used potassium iodide supplementation.
Median UICs in the three groups were 134.5 μg/L,
146 μg/L, and 183 μg/L, respectively. In several studies,
median UIC value >150 μg/L was associated with iodine
supplementation [30–34].
In most European countries, very low median UICs
have been reported, often less than 100 μg/L [14, 35],
Table 2 Iodine intake according to the questionnaire and related urinary iodine level
Urinary Iodine
≥150 μg/L
Urinary Iodine
<150 μg/L
pc Urinary iodine (μg/L)
Median [Q1-Q3]
pd
TRIMESTER 1 N = 538 N = 407 N = 945
Milka 0.016 0.003
0 glasses 85 (47.8%) 93 (52.2%) 139.5 [88.7–230.0]
1–2 glasses 372 (58.8%) 261 (41.2%) 176.0 [105.0–294.3]
> 2 glasses 81 (60.4%) 53 (39.6%) 198.0 [115.0–316.0]
Fishb 0.220 0.926
Non-consumption 31 (53.4%) 27 (46.6%) 165.0 [95.8–336.0]
1 serving 136 (55.5%) 109 (44.5%) 169.0 [104.0–282.5]
2 servings 163 (56.2%) 127 (43.8%) 168.5 [98.9–307.0]
3 servings 115 (57.5%) 85 (42.5%) 171.5 [104.2–261.2]
> 3 servings 93 (61.2%) 59 (38.8%) 180.0 [101.2–295.0]
Iodized salt <0.001 0.001
No 321 (52.8%) 287 (47.2%) 158.0 [95.3–278.0]
Yes 217 (64.4%) 120 (35.6%) 189.0 [116.5–305.0]
Iodine supplements <0.001 <0.001
No 234 (46.5%) 269 (53.5%) 140.0 [84.0–221.0]
Yes 304 (68.8%) 138 (31.2%) 209.5 [131.0–342.0]
aGlasses/day
bServings/week
cPearson’s chi-square test
dMann-Whitney U test
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with the exception of Switzerland, Sweden, Slovenia, and
some parts of Germany [36–40],
In the present study, UIC analysis in women who did
not take potassium iodide supplements revealed that
iodized salt intake along with milk consumption was
sufficient to maintain median UIC above 150 μg/L
(Table 3), although neither milk nor iodized salt intake
alone showed a relationship with this value.
Multivariate analysis disclosed the independent roles
of intake of milk, iodized salt, and supplementation on
the UIC. An association was found between milk con-
sumption and the UIC, and when iodized salt intake was
combined with this variable, protection against iodine
levels <150 μg/L was even higher, and similar to the pro-
tection obtained with supplementation (Table 3).
A similar association was detected in a recent study in
northern Spain (Asturias): pregnant women who con-
sumed 2 or more portions of dairy products per day had
a UIC of 230 μg/L, whereas those who consumed less
had a level of 191 μg/L. In addition, this study found a
median UIC ≥150 mg/L in pregnant women who con-
sumed iodized salt (41). In the study by Alvarez-Pedrerol
et al., there was no association between the UIC and the
foods included in their survey, with the exception of milk
[23]. These authors also found that increases in milk con-
sumption elicited a parallel increase in mean UIC values:
0 glasses/day, 78 μg/L; 1–2 glasses/day, 100 μg/L; and >2
glasses/day, 117 μg/L. A study in pregnant women
conducted in the United Kingdom also revealed a signifi-
cant positive association between milk consumption and
the UIC [41]: The mean urinary iodine/urinary creatinine
ratio value was 72 μg/g when milk consumption was
<140 mL/day, which rose to 150 μg/g when consumption
was more than 280 mL/day.
In Spain, the effect of milk consumption on the UIC
was first detected in a study carried out in children (4–
15 years old) more than 10 years ago [42]. Other studies
including a population of adults and children who did
not consume iodized salt, reported a median UIC of
more than 100 μg/L [24, 43–45], suggesting that other
sources of iodine in addition to iodized salt were being
consumed, such as dairy products. A recent analysis of
362 samples of milk from different parts of Spain
showed a mean iodine level of 259 (±58) μg/L [46].
Furthermore, in a sample of more than 4000 Spaniards
aged 18 years and older, there was a significant associ-
ation between milk consumption at least once a day and
a UIC >100 μg/L [1]. Similar results were observed in a
nationwide study conducted in a population of almost
2000 Spanish children [47]. The role of milk as a source
of iodine, as was seen in Spain, is recognized in other
European countries [48–53]. However, the “accidental
iodination” of milk, such as that occurring in the United
Kingdom [48], implies a risk of considerable variations
in iodine content if there is no regulation and control.
Australia has seen a drop in iodine nutrition due to a
decreased iodine content in its milk supply [54, 55].
Iodized salt is the food traditionally recommended by
the WHO and ICCIDD to ensure a proper level of
iodine nutrition in the population [56]. The risk of
iodine deficiency could be resolved if at least 90% of
households consumed iodized salt. In Spain, however,
iodized salt consumption in households is less than 50%
and in the case of pregnant women, 35.5% [1]. As in
other studies performed in our geographic area [23, 24],
no association was found between fish consumption and
the UIC in the pregnant women studied.
About 9% of our population had extreme UIC values
(>600 μg/L). Although potassium iodide supplementa-
tion was higher in this group, it is difficult to attribute
this to such a high UIC. However, seaweed consumption,
application of iodized antiseptics in pregnancy [57], and
use of salt with excessive iodination could justify UIC
values >600 mg/dL.
Table 3 Multivariate logistic regression analysis to determine the
role of dietary intake and iodine supplementation on the risk of
having an iodine level < 150 μg/L
β SE OR [95%CI] p
MODEL 1
Constant 0.633 — — — —
Daily milk consumption
No consumption Reference — — —
1–2 glasses −0.453 0.176 0.636 [0.45–0.90] 0.010
> 2 glasses −0.522 0.239 0.593 [0.37–0.95] 0.029
Iodized salt intake
No consumption Reference — — —
consumption −0.389 0.145 0.678 [0.51–0.90] 0.007
Iodine supplementation
No consumption Reference — — —
consumption −0.890 0.138 0.410 [0.31–0.54] <0.001
MODEL 2
Constant 0.617 — — — —
Iodized salt intake and daily milk consumption
No consumption Reference — — —
Only Iodized salt −0.351 0.320 0.704 [0.38–1.32] 0.276
Only Milk −0.445 0.216 0.641 [0.42–0.98] 0.039
Iodized salt and Milk −0.850 0.236 0.427 [0.27–0.68] <0.001
Iodine supplementation
No consumption Reference — — —
consumption −0.888 0.138 0.411 [0.31–0.54] <0.001
Result of exploratory multivariate logistic regression analysis. The dependent
variable was determined by the presence of UIC <150μg/L.
Model 1 shows the covariates that were statistically significant (p < 0.05),
taking under consideration Akaike’s information criterion and biological plausibility
Model 2 was obtained by combining salt intake and milk in a single variable
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Some studies have reported an association between
smoking and an increased risk of goiter or other thyroid
problems [18, 20, 24, 51, 58], but we did not find a
significant effect of tobacco use on UIC values.
Conclusion
In conclusion, the overall median UIC of women in their
first trimester of pregnancy found in our study is indica-
tive of adequate iodine nutritional status according to
the criteria established by the WHO and ICCIDD,
although 43.1% were found to have suboptimal levels.
Simultaneous consumption of iodized salt and milk was
as effective as potassium iodide supplementation to
achieve adequate iodine nutrition. The iodine concentra-
tion in salt in Spain (60 ppm) and the high concentra-
tion of iodine in cow milk, which has increased in recent
years, may explain these findings.
Women of childbearing age in our region should con-
sume iodized salt and milk to maintain an optimal UIC,
particularly those who are planning a pregnancy. A good
intra-thyroidal deposit of iodine enables the gland to
adapt and respond better to the physiologic changes that
occur during pregnancy. If women use these iodine-rich
products in the year before and during pregnancy, their
iodine status will likely be adequate and iodine supple-
mentation will not be necessary. Public health campaigns
should be developed in our setting to promote consump-
tion of iodized salt. Moreover, our national food agencies
should ensure adequately iodized salt and regular moni-
toring of iodine content in milk.
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